UiPath, Inc. (PATH) › Analysis

UiPath, Inc. (PATH) stock analysis, February 12, 2026: PATH tests $11.69 support after erasing the entire WorkFusion rally

Published February 12, 2026 · PATH chart, levels and live analysis

Key Updates

UiPath shares plunged 12.03% to $11.69 since the February 10 report, erasing the entire post-WorkFusion acquisition rally and establishing a new multi-week low. The sharp reversal follows the company's announcement of its Q4 fiscal 2026 earnings call scheduled for March 11, 2026, which appears to have triggered profit-taking after the brief 11.13% recovery rally. Year-to-date performance has deteriorated significantly to -28.68%, with the stock down 32.19% over the past month, indicating sustained selling pressure despite strategic initiatives. The decline suggests investors remain cautious ahead of fiscal year-end results and are potentially repositioning given broader market dynamics in the automation sector.

Current Trend

UiPath is experiencing severe downward momentum with YTD losses of 28.68%, placing the stock firmly in bearish territory. The current price of $11.69 represents a 12.03% decline from the $13.29 level achieved on February 10, effectively reversing the entire WorkFusion acquisition-driven rally. Technical pressure remains intense with the 1-month decline of 32.19% indicating capitulation-level selling. The brief 6-month gain of 11.97% has been completely overwhelmed by recent weakness, suggesting a structural breakdown in investor confidence. The stock is testing new support levels below $12, with no clear technical floor established. The 9.73% single-day decline on February 11 following the earnings announcement represents the sharpest drop in recent trading sessions, signaling heightened volatility and risk-off sentiment among shareholders ahead of fiscal results.

Investment Thesis

The investment thesis centers on UiPath's strategic positioning in the rapidly expanding agentic automation market, projected to grow from $3.60 billion in 2025 to $20.79 billion by 2032 at a 28.47% CAGR according to MMR Statistics. UiPath's competitive advantages include its No. 1 ranking on the OSWorld-Verified benchmark with Claude Opus 4.5-powered Screen Agent, demonstrating technical leadership in AI-driven automation (source). The WorkFusion acquisition strategically positions UiPath in the high-value financial services compliance market, addressing AML, KYC, and sanctions screening workflows that represent significant recurring revenue opportunities (source). Platform-centric vendors command 30-40% higher enterprise deal values compared to standalone providers, supporting UiPath's premium positioning. However, execution risk remains elevated as the company transitions from task-level automation to strategic enterprise-wide deployments while integrating WorkFusion's capabilities.

Thesis Status

The investment thesis faces near-term pressure as market sentiment deteriorates ahead of fiscal 2026 results, with the 28.68% YTD decline suggesting investors are discounting execution challenges or competitive threats. The sharp reversal of the WorkFusion acquisition rally indicates skepticism about integration timelines and synergy realization, particularly given the acquisition closed in Q1 fiscal 2027 with undisclosed financial terms. While UiPath's technical leadership remains validated through benchmark rankings and strategic market positioning in a high-growth sector is intact, the severe price decline reflects concerns about revenue growth sustainability, margin pressure from AI infrastructure investments, and competitive intensity from Microsoft, IBM, and other platform players. The upcoming March 11 earnings call represents a critical catalyst that could either validate the long-term thesis through strong guidance and WorkFusion integration metrics or confirm investor concerns about near-term headwinds. Current valuation compression creates potential opportunity for long-term investors if execution improves, but near-term risk remains elevated until fiscal results provide clarity on growth trajectory and profitability trends.

Key Drivers

The primary catalyst is UiPath's upcoming Q4 and full year fiscal 2026 earnings release scheduled for March 11, 2026, which will provide critical visibility into revenue growth, profitability trends, and forward guidance (source). The WorkFusion acquisition represents a strategic expansion into financial services compliance automation, potentially unlocking new revenue streams in AML, KYC, and sanctions screening workflows used by major global banks (source). Competitive dynamics intensify as the RPA market consolidates around platform leaders, with enterprises increasingly favoring integrated solutions over point products, benefiting established players like UiPath while increasing pressure to demonstrate differentiation (source). UiPath's technical leadership, validated by its No. 1 OSWorld benchmark ranking, provides competitive advantage in AI agent deployment, though sustained innovation investment is required to maintain this position (source). Broader market factors include increasing competition from specialized vendors like TeamDynamix entering Microsoft Marketplace and niche players like Unchained Labs launching AI-driven automation platforms, fragmenting the market and potentially pressuring pricing power (source, source).

Technical Analysis

UiPath has broken down through critical support at $12.89 (February 6 post-acquisition level) and $13.29 (February 10 high), establishing a new low at $11.69 with no clear technical support until the $11.00-$11.50 range. The 9.73% single-day decline represents a gap-down move that typically signals capitulation or negative catalyst anticipation. Short-term momentum indicators are deeply oversold with the 1-month decline of 32.19% exceeding typical correction parameters, suggesting potential for a technical bounce if earnings provide positive surprises. However, the failure to hold gains above $13 after the WorkFusion announcement indicates weak buying conviction and distribution by institutional holders. The 6-month gain of 11.97% has been completely erased by February's selling, with the stock now trading below all major moving averages. Resistance levels are established at $13.00 (psychological level), $13.29 (February 10 high), and $14.00 (prior support turned resistance). Volume patterns during the decline suggest genuine selling rather than low-liquidity volatility, increasing the probability of further downside without a fundamental catalyst. The March 11 earnings release represents the next major technical inflection point, with potential for significant volatility in either direction based on results and guidance.

Bull Case

Bear Case

Get a message when the PATH picture changes — the agent team watches the levels and the news for you.Create a free account

More PATH analyses